×
0 0.0498687664041995 0.0498687664041995 0.0498687664041995 0.0498687664041995 -0.0376202974628172 -0.125109361329834 -0.00637420322459692
Stockreport

Akers Biosciences Reports Earnings for Fiscal Year 2017

AKERS BIOSCIENCES INC COMMON S (AKER)  More Company Research Source: GlobeNewswire
US:NASDAQ Investor Relations: akersbio.com/investor-center
PDF Total Revenue Up 33% THOROFARE, N.J., April 03, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers”, “Akers Bio” or the "Company"), a developer of rapid health information technologies, reports its financial results for the fiscal year ended December 31, 2017. 2017 Financial Highlights: Total revenue up 33% to $3,929,527 (2016: $2,960,912)PIFA Heparin/PF4 Rapid Assay products continue to account for the majority of revenues – however, growth was driven primarily by BreathScan Alcohol Breathalyzers, BreathScan OxiChek™ and the re-introduced Tri-Cholesterol testTotal revenue up across all geographic regions USA: 23%China: 25%Rest of World: 247% Gross profit margin remained strong at 63% (2016: 63%)Gross profit up 34% to $2,509,564 (2016: $1,877,825)Major expense areas increased 17% overall General and Administrative expenses increased 36% to $4,082,313 (2016: $3,008,811) - the Company has been conservative in its approach to debt collect [Read more]

IMPACT SNAPSHOT EVENT TIME: AKER
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS